The estimated lifetime risk of being diagnosed with myeloma is 1 in 83 (1%) for males, and 1 in 116 (less than 1%) for females born after 1960 in the UK.
These figures have been calculated on the assumption that the possibility of having more than one diagnosis of myeloma over the course of a lifetime is very low (‘Current Probability’ method).
Lifetime risk for all cancers combined and cancers compared
Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator.
Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on Office for National Statistics (ONS) 2016-based Life expectancies and population projections. Accessed December 2017, and Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.
Esteve J, Benhamou E and Raymond L. Descriptive epidemiology. IARC Scientific Publications No.128, Lyon, International Agency for Research on Cancer, pp 67-68 1994.
About this data
Data is for UK, past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961, ICD-10 C90.
The calculations used past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961 to project risk over the lifetime of those born in 1961 (cohort method). Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment.